Skip to main content
 

Stay Connected

Get information and updates from the Biosimilars Forum

Sign Up

Become a Partner

Educational Resources

Check out our downloadable resources

Learn More

Policy

In 2015, the first biosimilar was approved in the U.S., and there are more than 50 biosimilars on the way. Their introduction may help expand access to high-quality treatment options for clinicians and patients and may reduce costs to families, caregivers, payers, and the health care system.

The Biosimilars Forum provides evidence-based information to educate and engage everyone involved—health care providers, payers, regulators, policymakers, patient advocates, and patients. The Biosimilars Forum will provide clear, unbiased information to help stakeholders better understand biosimilars and make wise decisions on policy and use.

Below is content on the pressing issues concerning policies, statements, and research that may encourage access, awareness, and adoption of biosimilars.

Biosimilars Forum Statements:

The Biosimilars Forum Comments on the FDA Proposed Guidance on the Naming of Biosimilars:

Links to Biosimilars Information from the FDA:

Biosimilars Forum: State Biosimilars Substitution Compromise

Biosimilars Reimbursement Study:

Biosimilars in the News:

Coalitions Support for Biosimilars: